{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:13:05Z","timestamp":1791162785657,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.jaad.2009.06.088","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T06:34:36Z","timestamp":1269326076000},"page":"309-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["New World cutaneous leishmaniasis: Updated review of current and future diagnosis and treatment"],"prefix":"10.1016","volume":"63","author":[{"given":"Panagiotis","family":"Mitropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pete","family":"Konidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy","family":"Durkin-Konidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.06.088_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","article-title":"The increase in risk factors for leishmaniasis worldwide","volume":"95","author":"Desjeux","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.0022-202x.2001.00038.x","article-title":"Leishmaniasis as an emerging infection","volume":"6","author":"Choi","year":"2001","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2009.06.088_bib3","unstructured":"Hsia R. Leishmaniasis. Available from: URL:http:\/\/www.emedicine.com\/emerg\/topic296.htm. Accessed on March 23, 2009."},{"key":"10.1016\/j.jaad.2009.06.088_bib4","unstructured":"Centers for Disease Control and Prevention (CDC). The yellow book, health information for travelers, CDC 2010. Available at\u00a0http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2010\/chapter-5\/cutaneous-leishmaniasis.aspx. Accessed February 8, 2010."},{"key":"10.1016\/j.jaad.2009.06.088_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0035-9203(93)90398-A","article-title":"Fifteen years of cutaneous mucocutaneous leishmaniasis in Bolivia: a retrospective study","volume":"87","author":"David","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1808-8694(15)31181-2","article-title":"Mucosal leishmaniasis: epidemiological and clinical aspects","volume":"73","author":"Lessa","year":"2007","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.jaad.2009.06.088_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1590\/S0102-311X2000000400013","article-title":"The epidemiology and control of leishmaniasis in Andean countries","volume":"16","author":"Davies","year":"2000","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.jaad.2009.06.088_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4269\/ajtmh.1998.58.589","article-title":"Epidemiologic characterization of American cutaneous leishmaniasis in an endemic region of eastern Venezuela","volume":"58","author":"Jorquera","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib9","first-page":"614","article-title":"Leishmaniasis in Washington County","volume":"47","author":"McHugh","year":"2002","journal-title":"Texas. J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.06.088_bib10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaad.2007.11.008","article-title":"Cutaneous leishmaniasis in Texas: a northern spread of endemic areas","volume":"58","author":"Wright","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.06.088_bib11","series-title":"Fitzpatrick's dermatology in general medicine","first-page":"2001","volume":"Vol 11","author":"Ghosn","year":"2008"},{"key":"10.1016\/j.jaad.2009.06.088_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1034\/j.1600-0560.2003.00125.x","article-title":"Identification of parasite antigen, correlation of parasite density and inflammation in skin lesions of post kala-azar dermal leishmaniasis","volume":"30","author":"Beenal","year":"2003","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2009.06.088_bib13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0020-7519(03)00179-6","article-title":"Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different processes and status protection in BALB\/c mice","volume":"33","author":"Courret","year":"2003","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.jaad.2009.06.088_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(06)70492-3","article-title":"New World cutaneous leishmaniasis in travelers","volume":"6","author":"Schwartz","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/qjmed\/hch127","article-title":"New World mucosal and cutaneous leishmaniasis: an emerging health problem among British travelers","volume":"97","author":"Lawn","year":"2004","journal-title":"QJM"},{"key":"10.1016\/j.jaad.2009.06.088_bib16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Leishmaniasis. Lancet"},{"key":"10.1016\/j.jaad.2009.06.088_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/0022-3859.928","article-title":"Cutaneous leishmaniasis: an overview","volume":"49","author":"Hepburn","year":"2003","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.jaad.2009.06.088_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaad.2009.06.088_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/524042","article-title":"Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru","volume":"46","author":"Llanos-Cuentas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/503371","article-title":"Resistance to antimony and treatment failure in human Leishmania (viannia) infection","volume":"193","author":"Rojas","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5144\/0256-4947.1998.412","article-title":"Recent trends in the treatment of cutaneous leishmaniasis","volume":"18","author":"Alkhwajah","year":"1998","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.jaad.2009.06.088_bib22","first-page":"161","article-title":"A double blind, randomized placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis","volume":"43","author":"Kochar","year":"2006","journal-title":"J Vector Borne Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/qjmed\/93.11.733","article-title":"The role of rifampicin in the management of cutaneous leishmaniasis","volume":"93","author":"Kochar","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.jaad.2009.06.088_bib24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(05)78687-6","article-title":"Treatment of cutaneous leishmaniasis in Colombia with dapsone","volume":"351","author":"Osorio","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2009.06.088_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0035-9203(81)90086-9","article-title":"Further trials of nifurtimox in mucocutaneous leishmaniasis","volume":"75","author":"Guena","year":"1981","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib26","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1128\/IAI.01073-06","article-title":"CXCL10\/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice","volume":"74","author":"Vasquez","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaad.2009.06.088_bib27","first-page":"72","article-title":"Effects of anti- Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae)","volume":"83","author":"Anjili","year":"2006","journal-title":"East Afr Med J"},{"key":"10.1016\/j.jaad.2009.06.088_bib28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jac\/43.6.793","article-title":"The antileishmanial activity of novel oxygenated chalcones and their mechanism of action","volume":"43","author":"Zhai","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2009.06.088_bib29","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1039\/b703521g","article-title":"Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation","volume":"6","author":"Akilov","year":"2007","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.jaad.2009.06.088_bib30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/archderm.139.4.432","article-title":"Treatment of cutaneous leishmaniasis with photodynamic therapy","volume":"139","author":"Claes","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.06.088_bib31","unstructured":"The Sanger Centre. Sequencing projects. Available from: URL:http:\/\/www.sanger.ac.uk\/Projects\/. Accessed March 25, 2009."},{"key":"10.1016\/j.jaad.2009.06.088_bib32","series-title":"Leishmania: after the genome","author":"Myler","year":"2008"},{"key":"10.1016\/j.jaad.2009.06.088_bib33","series-title":"Tropical and geographical medicine","first-page":"270","article-title":"Leishmaniasis","author":"Wyler","year":"1984"},{"key":"10.1016\/j.jaad.2009.06.088_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0738-081X(96)00048-X","article-title":"Treatment of New World cutaneous and mucosal leishmaniasis","volume":"14","author":"Berman","year":"1996","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2009.06.088_bib36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"Navin","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2005.72.133","article-title":"Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis","volume":"72","author":"Andersen","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","article-title":"Treatment of cutaneous leishmaniasis among travelers","volume":"53","author":"Blum","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2009.06.088_bib39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodier","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib40","first-page":"487","article-title":"Management of cutaneous leishmaniasis in adults and children","volume":"65","author":"Minodier","year":"2005","journal-title":"Med Trop (Mars)"},{"key":"10.1016\/j.jaad.2009.06.088_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/00034983.2001.11813645","article-title":"Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana","volume":"95","author":"Nacher","year":"2001","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.jaad.2009.06.088_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/341406","article-title":"A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel","volume":"35","author":"Wortmann","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/clinids\/18.3.381","article-title":"Efficacy of a short course (10 days) of high-dose meglumine antimoniate with or without interferon-gamma in treating cutaneous leishmaniasis in Guatemala","volume":"18","author":"Arana","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib44","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4269\/ajtmh.1997.57.651","article-title":"A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years)","volume":"57","author":"Oliveira-Neto","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/S0037-86822006000400001","article-title":"An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable","volume":"39","author":"Oliveira-Neto","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.jaad.2009.06.088_bib46","first-page":"496","article-title":"Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg\/kg\/day) and high dosage (20 mg\/kg\/day) antimony regimens","volume":"45","author":"Oliveira-Neto","year":"1997","journal-title":"Pathol Biol"},{"key":"10.1016\/j.jaad.2009.06.088_bib47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/S0074-02761996000200016","article-title":"High and low doses of antimony (Sbv) in American cutaneous leishmaniasis: a five years follow-up study of 15 patients","volume":"91","author":"Oliveira-Neto","year":"1996","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jaad.2009.06.088_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-4362.1997.00188.x","article-title":"Intralesional therapy on American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil\u2013an area of Leishmania (V.) braziliensis transmission","volume":"36","author":"Oliveira-Neto","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.088_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4269\/ajtmh.1994.50.107","article-title":"Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine","volume":"50","author":"Soto","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib50","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/clind\/16.3.417","article-title":"Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia","volume":"16","author":"Soto-Mancipe","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2310\/7060.2004.19109","article-title":"Itraconazole can be effective in the treatment of sporotrichoid leishmaniasis","volume":"11","author":"Morelli","year":"2004","journal-title":"J Travel Med"},{"key":"10.1016\/j.jaad.2009.06.088_bib52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2230.1986.tb00425.x","article-title":"Cutaneous leishmaniasis from Belize\u2013treatment with ketoconazole","volume":"11","author":"Jolliffe","year":"1986","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.06.088_bib53","first-page":"198","article-title":"Failure of oral ketoconazole to cure cutaneous ulcers caused by Leishmania braziliensis","volume":"38","author":"Dan","year":"1986","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2009.06.088_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","article-title":"Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis","volume":"89","author":"Saenz","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2009.06.088_bib55","first-page":"163","article-title":"Recent advances in antileishmanial drug development","volume":"6","author":"Davis","year":"2005","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.jaad.2009.06.088_bib56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0020-7519(93)90104-7","article-title":"Topical treatment of cutaneous leishmaniasis in Belize: in vitro and in vivo studies with Leishmania mexicana","volume":"23","author":"El-On","year":"1993","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.jaad.2009.06.088_bib57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1590\/S0074-02762001000200005","article-title":"Clinical picture of cutaneous leishmaniasis due to Leishmania(Leishmania) mexicana in the Yucatan peninsula, Mexico","volume":"96","author":"Andrade-Narvaez","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jaad.2009.06.088_bib58","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4269\/ajtmh.1986.35.1110","article-title":"Leishmania major: antileishmanial activity of methylbenzethonium chloride","volume":"35","author":"El-on","year":"1986","journal-title":"Am J Trop Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib59","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of tropical treatment of methylbenzethonium chloride ointment in Guatemala","volume":"65","author":"Arana","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib60","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0035-9203(97)90290-X","article-title":"Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin","volume":"91","author":"Neva","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","article-title":"Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis","volume":"91","author":"Armijos","year":"2004","journal-title":"Acta Trop"},{"key":"10.1016\/j.jaad.2009.06.088_bib62","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/516267","article-title":"Topical paromomycin\/methylbenzethonium chloride plus parenteral meglumine antimoniate as treatment for American cutaneous leishmaniasis: controlled study","volume":"26","author":"Soto","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/clinids\/20.1.47","article-title":"Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin\/methylbenzethonium chloride and injectable meglumine antimoniate","volume":"20","author":"Soto","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib64","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2307\/3285646","article-title":"Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (aminosidine) and gentamicin","volume":"85","author":"Grogl","year":"1999","journal-title":"J Parasitol"},{"key":"10.1016\/j.jaad.2009.06.088_bib65","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4269\/ajtmh.2002.66.147","article-title":"Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study","volume":"66","author":"Soto","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib66","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaad.2006.06.044","article-title":"Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis","volume":"56","author":"Solomon","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.06.088_bib67","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5694\/j.1326-5377.2007.tb00910.x","article-title":"An Australian case of New World cutaneous leishmaniasis","volume":"186","author":"Konecny","year":"2007","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaad.2009.06.088_bib68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2133.2005.06670.x","article-title":"Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis","volume":"153","author":"Brown","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.088_bib69","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/0006-2952(87)90543-0","article-title":"The activity of alkylphosphocholines and related derivatives against Leishmania donovani","volume":"36","author":"Croft","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaad.2009.06.088_bib70","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.36.8.1630","article-title":"Hexadecyl phosphocholine; oral treatment of visceral leishmaniasis in mice","volume":"36","author":"Kuhlencord","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2009.06.088_bib71","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for New World cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.06.088_bib72","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.trstmh.2006.02.011","article-title":"Oral miltefosine for the treatment of Indian visceral leishmaniasis","volume":"100","author":"Sundar","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib73","first-page":"132","article-title":"Miltefosine in cutaneous leishmaniasis","volume":"17","author":"Simeen","year":"2007","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.jaad.2009.06.088_bib74","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Efficacy of miltefosine for Bolivian cutaneous leishmaniasis","volume":"78","author":"Soto","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.06.088_bib75","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.trstmh.2006.02.022","article-title":"Treatment of New World cutaneous leishmaniasis with miltefosine","volume":"100","author":"Soto","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib76","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1086\/322689","article-title":"Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent","volume":"33","author":"Soto","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib77","first-page":"122","article-title":"Imiquimod cream: a new multipurpose topical therapy for dermatology","volume":"28","author":"Najarian","year":"2003","journal-title":"Pharmacy & Therapeutics"},{"key":"10.1016\/j.jaad.2009.06.088_bib78","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1006\/cyto.1997.0239","article-title":"Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463","volume":"9","author":"Wagner","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.jaad.2009.06.088_bib79","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunoregulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib80","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/429238","article-title":"Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru","volume":"40","author":"Miranda-Verastegui","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib81","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator","volume":"33","author":"Arevalo","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib82","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1086\/518172","article-title":"Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis","volume":"44","author":"Arevalo","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib83","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/AAC.5.5.469","article-title":"Antileishmanial effect of allopurinol","volume":"5","author":"Pfaller","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2009.06.088_bib84","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/24.2.165","article-title":"Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate","volume":"24","author":"Martinez","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib85","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM199203123261105","article-title":"Allopurinol in the treatment of American cutaneous leishmaniasis","volume":"326","author":"Martinez","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2009.06.088_bib86","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4269\/ajtmh.1991.45.92","article-title":"Placebo controlled treatment of Ecuadorian cutaneous leishmaniasis","volume":"45","author":"Guderian","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2009.06.088_bib87","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/infdis\/160.1.153","article-title":"Treatment of American cutaneous leishmaniasis with orally administered allopurinol riboside","volume":"160","author":"Saenz","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib88","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-126-3-199702010-00010","article-title":"Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis: a randomized, controlled trial","volume":"126","author":"Velez","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2009.06.088_bib89","series-title":"Tropical infectious diseases: principles, pathogens and practice","first-page":"1095","article-title":"Leishmaniasis","author":"Jeronimo","year":"2006"},{"key":"10.1016\/j.jaad.2009.06.088_bib90","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2009.06.088_bib91","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"Khamesipour","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jaad.2009.06.088_bib92","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4049\/jimmunol.165.2.915","article-title":"Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells","volume":"165","author":"Gurunathan","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2009.06.088_bib93","first-page":"455","article-title":"Genetically modified live attenuated parasites as vaccines for leishmaniasis","volume":"123","author":"Selvapandiyan","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jaad.2009.06.088_bib94","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application and optimization","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaad.2009.06.088_bib95","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2009.06.088_bib96","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection","volume":"195","author":"Rhee","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2009.06.088_bib97","doi-asserted-by":"crossref","first-page":"F7","DOI":"10.1084\/jem.194.3.F7","article-title":"Leishmaniasis vaccination: targeting the source of infection","volume":"194","author":"Reed","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2009.06.088_bib98","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the New World: current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaad.2009.06.088_bib99","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: a deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2009.06.088_bib100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/bmj.325.7357.176","article-title":"The world's most neglected diseases","volume":"325","author":"Yamey","year":"2002","journal-title":"BMJ"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.06.088_bib101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00034983.1995.11813017","article-title":"Vaccines against leishmaniasis","volume":"89","author":"Modabber","year":"1995","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.jaad.2009.06.088_bib102","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3201\/eid1407.071589","article-title":"Spread of vector-borne diseases and neglect of leishmaniasis, Europe","volume":"14","author":"Dujardin","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030295","article-title":"Climate cycles and forecasts of cutaneous leishmaniasis, a nonstationary vector-borne disease","volume":"3","author":"Chaves","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaad.2009.06.088_bib104","unstructured":"World Health Organization. Leishmaniasis and Leishmania\/HIV co-infection. WHO report on global surveillance of epidemic-prone infectious diseases. Available at: http:\/\/www.who.int\/csr\/resources\/publications\/surveillance\/Leishmaniasis.pdf. Accessed February 7, 2010."},{"key":"10.1016\/j.jaad.2009.06.088_bib105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/318476","article-title":"Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature","volume":"32","author":"Bogdan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.06.088_bib106","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-3156.2007.01998.x","article-title":"The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors","volume":"13","author":"Maroli","year":"2008","journal-title":"Trop Med Int Health"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209011487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209011487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:16:19Z","timestamp":1759270579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209011487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0190962209011487"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.06.088","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New World cutaneous leishmaniasis: Updated review of current and future diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.06.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}